Recomienda este artículo a tus amigos:
Resistance to Ibritumomab in Lymphoma - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2018 edition
Resistance to Ibritumomab in Lymphoma - Resistance to Targeted Anti-Cancer Therapeutics
This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
158 pages, 11 Tables, color; 14 Illustrations, color; 4 Illustrations, black and white; XIII, 158 p.
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 8 de enero de 2019 |
| ISBN13 | 9783030086527 |
| Editores | Springer Nature Switzerland AG |
| Páginas | 158 |
| Dimensiones | 150 × 220 × 10 mm · 254 g |
| Lengua | Alemán |
| Editor | Chatal, Jean-Francois |
| Editor | Hosono, Makoto |